IP Verse

Compositions Of Glp-1 Peptides And Preparation Thereof

Patent No. EP3488857 (titled "Compositions Of Glp-1 Peptides And Preparation Thereof") was filed by Novo Nordisk on Mar 15, 2013. The application was issued on Oct 4, 2023.

Patent Summary

Improving oral delivery of GLP-1 peptides like glucagon-like peptide-1 (GLP-1) for treating diabetes and obesity. The invention involves designing granules for tablet formulations containing GLP-1 peptides and delivery agents like SNAC. The granules are prepared by mixing the peptide, fillers, and binders, then the delivery agent mix. This two-step granulation process allows separate optimization of peptide and delivery properties. The resulting granules have improved dissolution profiles for faster GLP-1 release compared to co-granulating.

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKMar 7, 2024TER MEER STEINMEISTER & PARTNER
HAMM & WITTKOPPMar 7, 2024HAMM & WITTKOPP
HEXALMar 7, 2024MAIWALD
POLPHARMAMar 7, 2024MAIWALD
STRAWMANMar 5, 2024HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3488857

NOVO NORDISK
Application Number
EP18188815A
Filing Date
Mar 15, 2013
Status
Granted And Under Opposition
May 5, 2023
Publication Date
Oct 4, 2023
External Links
Slate, Register , Google Patents